Contact
searchSearch
HMP Global

Venous Disease Topic Center

Features

Dr Xhorlina Marko
ISET 2025
An Update on the Data and Devices for the Treatment of DVT
03/21/2025
Iinterventional radiologist Xhorlina Marko, MD, from Henry Ford Health in Detroit, Michigan, discusses the details of her ISET 2025 presentation on the latest data and devices for DVT treatment.
Iinterventional radiologist Xhorlina Marko, MD, from Henry Ford Health in Detroit, Michigan, discusses the details of her ISET 2025 presentation on the latest data and devices for DVT treatment.
Iinterventional radiologist...
03/21/2025
Vascular Disease Management
Interview
STRIKE-PE: Interim Analysis of the First 300 Patients Using Lightning Flash
03/05/2025
Brian J. Schiro, MD
VDM spoke with Dr Schiro about STRIKE-PE, a study that evaluated the efficacy and long-term safety outcomes of treating PE with Lightning Flash (Penumbra).
VDM spoke with Dr Schiro about STRIKE-PE, a study that evaluated the efficacy and long-term safety outcomes of treating PE with Lightning Flash (Penumbra).
VDM spoke with Dr Schiro about...
03/05/2025
Vascular Disease Management
Interview
The PEERLESS Trial: What Are the Implications for the Management of Pulmonary Embolism?
02/26/2025
Ripal T. Gandhi, MD, FSIR, FSVM
Ripal Gandhi, MD, speaks with Vascular Disease Management about his presentation at ISET 2025 on the PEERLESS trial.
Ripal Gandhi, MD, speaks with Vascular Disease Management about his presentation at ISET 2025 on the PEERLESS trial.
Ripal Gandhi, MD, speaks with...
02/26/2025
Vascular Disease Management
Dr Harnain
ISET 2025
Case Studies & Discussion: Venous Compression Syndromes
02/02/2025
Read about Dr Christopher M. Harnain's ISET 2025 presentation on venous compression syndromes.
Read about Dr Christopher M. Harnain's ISET 2025 presentation on venous compression syndromes.
Read about Dr Christopher M....
02/02/2025
Vascular Disease Management
Dr Jaffer
LINC 2025
Creating EndoAVF: New Evidence and Upcoming Trials
01/30/2025
Ounali Jaffer, MD, walked through his experience in using endoAVF and touched on the past, present, and future insights that may potentially drive this field. 
Ounali Jaffer, MD, walked through his experience in using endoAVF and touched on the past, present, and future insights that may potentially drive this field. 
Ounali Jaffer, MD, walked...
01/30/2025
Vascular Disease Management
Dr Hirsch
LINC 2025
Odds and Limitations of Duplex Sonography in the Diagnosis of PeVD
01/28/2025
Tobias Hirsch, MD
Dr Tobias Hirsch discusses his LINC 2025 presentation on diagnosing pelvic venous disorders with duplex sonography.
Dr Tobias Hirsch discusses his LINC 2025 presentation on diagnosing pelvic venous disorders with duplex sonography.
Dr Tobias Hirsch discusses his...
01/28/2025
Vascular Disease Management
Original Research
Impact of Deep Venous Stenting on Healing Rates of Venous Leg Ulcers
01/23/2025
Antonio Solano, MD; Andrea Klein, MD; Gerardo Gonzalez-Guardiola, MD; Khalil Chamseddin, MD; Michael Shih, MD; Vivek Prakash, MD; Shadman Baig, MD; Carlos H Timaran, MD; Melissa L Kirkwood, MD; Michael Siah, MD
Venous leg ulcers (VLUs) have a significant symptomatic and quality-of-life burden for patients with CVI despite medical treatment and wound care. This study reports the impact of deep venous stenting in patients with chronic VLUs.
Venous leg ulcers (VLUs) have a significant symptomatic and quality-of-life burden for patients with CVI despite medical treatment and wound care. This study reports the impact of deep venous stenting in patients with chronic VLUs.
Venous leg ulcers (VLUs) have a...
01/23/2025
Vascular Disease Management
Interview
Using Artificial Intelligence to Diagnose Pulmonary Embolism
01/15/2025
Patrick Muck, MD
Dr Patrick Muck discusses how AI enhances the speed and accuracy of a PE diagnosis and what the future may hold for AI to diagnose other vascular diseases.
Dr Patrick Muck discusses how AI enhances the speed and accuracy of a PE diagnosis and what the future may hold for AI to diagnose other vascular diseases.
Dr Patrick Muck discusses how AI...
01/15/2025
Vascular Disease Management
Interview
The American Vein and Lymphatic Society Position Statement on Mechanical Occlusion Chemically Assisted Ablation of Varicose Veins for Venous Insufficiency
12/01/2024
John Blebea, MD, MBA
John Blebea, MD, MBA, from the Central Michigan University College of Medicine in Saginaw, Michigan, discusses latest position statement of the AVLS on mechanical occlusion chemically assisted ablation.
John Blebea, MD, MBA, from the Central Michigan University College of Medicine in Saginaw, Michigan, discusses latest position statement of the AVLS on mechanical occlusion chemically assisted ablation.
John Blebea, MD, MBA, from the...
12/01/2024
Vascular Disease Management
Late-Breaking Trials
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/05/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/05/2024
Vascular Disease Management
Late-Breaking Trials
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management

Videos & Podcasts

Dr Xhorlina Marko
ISET 2025
An Update on the Data and Devices for the Treatment of DVT
03/21/2025
Iinterventional radiologist Xhorlina Marko, MD, from Henry Ford Health in Detroit, Michigan, discusses the details of her ISET 2025 presentation on the latest data and devices for DVT treatment.
Iinterventional radiologist Xhorlina Marko, MD, from Henry Ford Health in Detroit, Michigan, discusses the details of her ISET 2025 presentation on the latest data and devices for DVT treatment.
Iinterventional radiologist...
03/21/2025
Vascular Disease Management
Dr Viridia and Dr Gandhi
Sponsored Video
A Physician’s Perspective on IVC Filters
04/02/2024
Ripal T. Gandhi, MD, FSIR, FSVM; Neal Viridia, MD
Join Dr. Ripal Gandhi and Dr. Neal Viradia as they discuss how the PRESERVE data impacted their filter placements and retrievals and how Option ELITE provides the safety, retrievability and versatility they look for in an IVC filter.
Join Dr. Ripal Gandhi and Dr. Neal Viradia as they discuss how the PRESERVE data impacted their filter placements and retrievals and how Option ELITE provides the safety, retrievability and versatility they look for in an IVC filter.
Join Dr. Ripal Gandhi and Dr....
04/02/2024
Vascular Disease Management
Dr Osman Ahmed
ISET 2024
Management of Acute and Chronic Lower Extremity Venous Obstruction
03/05/2024

Osman Ahmed, MD
UChicago Medicine, Chicago, Illinois

Osman Ahmed, MD UChicago Medicine, Ch...
Watch as Dr. Osman Ahmed discusses his ISET 2024 presentation on acute and chronic lower extremity venous obstruction.
Watch as Dr. Osman Ahmed discusses his ISET 2024 presentation on acute and chronic lower extremity venous obstruction.
Watch as Dr. Osman Ahmed...
03/05/2024
Vascular Disease Management
Dr Daye
ISET 2024
Potential AI Applications for Intervention; AI for Venous Disease
02/09/2024
Dania Daye, MD, PhD
In this video, Dr. Dania Daye discusses her ISET 2024 presentations on the use of artificial intelligence in interventional specialties.
In this video, Dr. Dania Daye discusses her ISET 2024 presentations on the use of artificial intelligence in interventional specialties.
In this video, Dr. Dania Daye...
02/09/2024
Vascular Disease Management
Dr Sista
ISET 2024
Update on the Data: Devices for Treatment of Pulmonary Embolism
02/09/2024
Akhilesh K. Sista, MD
Dr Akhilesh Sista discusses his ISET 2024 presentation on the latest data from current studies on treating pulmonary embolism with catheter-directed therapy.
Dr Akhilesh Sista discusses his ISET 2024 presentation on the latest data from current studies on treating pulmonary embolism with catheter-directed therapy.
Dr Akhilesh Sista discusses his...
02/09/2024
Vascular Disease Management
Dr N'Dandu
AMP 2023
Latest Results of the PROMISE II US Pivotal Trial of the LimFlow System
10/04/2023
In this video recorded at AMP 2023, interventional cardiologist Zola N'Dandu, MD, discusses his presentation on the latest results of the PROMISE II U.S. Pivotal Trial, which investigated the safety and effectiveness of the LimFlow System.
In this video recorded at AMP 2023, interventional cardiologist Zola N'Dandu, MD, discusses his presentation on the latest results of the PROMISE II U.S. Pivotal Trial, which investigated the safety and effectiveness of the LimFlow System.
In this video recorded at AMP...
10/04/2023
Vascular Disease Management
Venclose RF Ablation Catheter
Video
Choose RF Ablation Using the Venclose™ RF Ablation Catheter Featuring Dual Heating Lengths
06/26/2023
Watch this video on the Venclose™ RF Ablation Catheter.
Watch this video on the Venclose™ RF Ablation Catheter.
Watch this video on the...
06/26/2023
Vascular Disease Management
Drs Ahmed, Paul, Secemsky, and Sista
Vascular Voices Podcast
Pulmonary Embolism: Where We Are and Where We’re Going
02/15/2023
Osman Ahmed, MD; Akhilesh K. Sista, MD; Jonathan D. Paul, MD; Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI
In this episode of Vascular Voices, interventional radiologists Osman Ahmed, MD and Akhi Sista, MD and interventional cardiologists Jonathan Paul, MD and Eric Secemsky, MD discuss the latest advancements in pulmonary embolism treatment.
In this episode of Vascular Voices, interventional radiologists Osman Ahmed, MD and Akhi Sista, MD and interventional cardiologists Jonathan Paul, MD and Eric Secemsky, MD discuss the latest advancements in pulmonary embolism treatment.
In this episode of Vascular...
02/15/2023
Vascular Disease Management
Dr Rundback
ISET 2023
Expected Duplex Findings After DVA and How These Evolve
02/09/2023
John H. Rundback, MD, FAHA, FSIR
Watch as Interventional Radiologist Dr. John Rundback describes his presentation on duplex findings after deep venous arterialization at ISET 2023.
Watch as Interventional Radiologist Dr. John Rundback describes his presentation on duplex findings after deep venous arterialization at ISET 2023.
Watch as Interventional...
02/09/2023
Vascular Disease Management
Venclose Maven
VIdeos
Venclose Maven: The Only 360° RF Solution for the Treatment of Incompetent Perforator Veins
11/10/2022
Learn about the Venclose Maven Perforator Catheter from BD Venous.
Learn about the Venclose Maven Perforator Catheter from BD Venous.
Learn about the Venclose Maven...
11/10/2022
Vascular Disease Management
Dr Setayesh Sotoudehnia
Interview
Making the Impossible Possible: MR-Guided Interventional Oncology
03/27/2025
Setayesh Sotoudehnia, MD
Ahead of SIR 2025, Dr Setayesh Sotoudehnia of Mayo Clinic Rochester speaks about her research on MR-guided procedures, her GCAW Award, and the advancement of women in the field of interventional radiology.
Ahead of SIR 2025, Dr Setayesh Sotoudehnia of Mayo Clinic Rochester speaks about her research on MR-guided procedures, her GCAW Award, and the advancement of women in the field of interventional radiology.
Ahead of SIR 2025, Dr Setayesh...
03/27/2025
Vascular Disease Management
Dr Peter Schneider
ISET 2025
Handicapping the CREST 2 Trial: Possible Outcome Scenarios and Impact on Patient Care
03/27/2025
Peter A. Schneider, MD, FACS
In this video, Peter Schneider, MD, discusses his ISET 2025 presentation on the CREST 2 trial, which completed enrollment in August 2024.
In this video, Peter Schneider, MD, discusses his ISET 2025 presentation on the CREST 2 trial, which completed enrollment in August 2024.
In this video, Peter Schneider,...
03/27/2025
Vascular Disease Management
Dr Ramon Varcoe
ISET 2025
The Role of Bioresorbable Stents in Tibial Disease: When and Where?
03/26/2025
Ramon L. Varcoe, MBBS, MS, PhD
Dr Ramon Varcoe discusses his ISET 2025 presentation on the efficacy and safety of bioresorbable drug-coated balloons in treating infrapopliteal arterial disease.
Dr Ramon Varcoe discusses his ISET 2025 presentation on the efficacy and safety of bioresorbable drug-coated balloons in treating infrapopliteal arterial disease.
Dr Ramon Varcoe discusses his...
03/26/2025
Vascular Disease Management
Dr Jay Mathews
ISET 2025
DETOUR Patient Selection in Complex PAD: Expert Insights from Dr. Jay Mathews
03/24/2025
S. Jay Mathews, MD, MS, FACC, FSCAI
Dr. Jay Mathews breaks down the key clinical and anatomical factors in selecting the right patients for the DETOUR procedure in complex peripheral artery disease.
Dr. Jay Mathews breaks down the key clinical and anatomical factors in selecting the right patients for the DETOUR procedure in complex peripheral artery disease.
Dr. Jay Mathews breaks down the...
03/24/2025
Vascular Disease Management
Dr Dania Daye
ISET 2025
AI Governance in Procedural Practices: Who and How to Decide What Algorithms to Implement
03/24/2025
Dania Daye, MD, PhD
Dania Daye, MD, PhD, discusses her ISET 2025 presentation on ensuring that the AI systems and tools being used in your practice are safe and ethical.
Dania Daye, MD, PhD, discusses her ISET 2025 presentation on ensuring that the AI systems and tools being used in your practice are safe and ethical.
Dania Daye, MD, PhD, discusses...
03/24/2025
Vascular Disease Management
Dr William Gray
ISET 2025
The Next Generation of Radiation Protection Solutions: The Dynamic SMART Shield
03/21/2025
William A. Gray, MD, FACC, FSCAI; Ripal T. Gandhi, MD, FSIR, FSVM
ISET co-directors Bill Gray, MD, and Ripal Gandhi, MD, discuss the critical challenges of developing an ideal scatter radiation protection system.
ISET co-directors Bill Gray, MD, and Ripal Gandhi, MD, discuss the critical challenges of developing an ideal scatter radiation protection system.
ISET co-directors Bill Gray, MD,...
03/21/2025
Vascular Disease Management
Dr Xhorlina Marko
ISET 2025
An Update on the Data and Devices for the Treatment of DVT
03/21/2025
Iinterventional radiologist Xhorlina Marko, MD, from Henry Ford Health in Detroit, Michigan, discusses the details of her ISET 2025 presentation on the latest data and devices for DVT treatment.
Iinterventional radiologist Xhorlina Marko, MD, from Henry Ford Health in Detroit, Michigan, discusses the details of her ISET 2025 presentation on the latest data and devices for DVT treatment.
Iinterventional radiologist...
03/21/2025
Vascular Disease Management
Dr Sanjay Misra
ISET 2025
Present and Future Applications of AI in Vascular Therapy
03/20/2025
Watch as interventional radiologist Sanjay Misra, MD, FSIR, professor of radiology at the Mayo Clinic in Rochester, Minnesota, discusses his ISET 2025 presentation on how artificial intelligence is currently used in vascular therapy.
Watch as interventional radiologist Sanjay Misra, MD, FSIR, professor of radiology at the Mayo Clinic in Rochester, Minnesota, discusses his ISET 2025 presentation on how artificial intelligence is currently used in vascular therapy.
Watch as interventional...
03/20/2025
Vascular Disease Management
Dr Parikh
ISET 2025
The Current Role of PAE in the Management of Prostate Cancer
03/18/2025
Nainesh Parikh
In this video from ISET2025, interventional radiologist Dr Nainesh Parikh discusses his presentation on the benefits of prostatic artery embolization in the treatment of prostate cancer.
In this video from ISET2025, interventional radiologist Dr Nainesh Parikh discusses his presentation on the benefits of prostatic artery embolization in the treatment of prostate cancer.
In this video from ISET2025,...
03/18/2025
Vascular Disease Management
Dr Daniel Clair
ISET 2025
First Clinical Use of a Novel Forward-Shifted Peripheral Intravascular Lithotripsy System: Primary Outcomes of the FORWARD IDE and Feasibility Studies
03/17/2025
Daniel G. Clair, MD
In this video, Dr Daniel Clair, discusses the key findings of the FORWARD PAD IDE trial and its feasability studies.
In this video, Dr Daniel Clair, discusses the key findings of the FORWARD PAD IDE trial and its feasability studies.
In this video, Dr Daniel Clair, ...
03/17/2025
Vascular Disease Management

Presentations

Dr Harnain
ISET 2025
Case Studies & Discussion: Venous Compression Syndromes
02/02/2025
Read about Dr Christopher M. Harnain's ISET 2025 presentation on venous compression syndromes.
Read about Dr Christopher M. Harnain's ISET 2025 presentation on venous compression syndromes.
Read about Dr Christopher M....
02/02/2025
Vascular Disease Management
Dr Jaffer
LINC 2025
Creating EndoAVF: New Evidence and Upcoming Trials
01/30/2025
Ounali Jaffer, MD, walked through his experience in using endoAVF and touched on the past, present, and future insights that may potentially drive this field. 
Ounali Jaffer, MD, walked through his experience in using endoAVF and touched on the past, present, and future insights that may potentially drive this field. 
Ounali Jaffer, MD, walked...
01/30/2025
Vascular Disease Management
Dr Hirsch
LINC 2025
Odds and Limitations of Duplex Sonography in the Diagnosis of PeVD
01/28/2025
Tobias Hirsch, MD
Dr Tobias Hirsch discusses his LINC 2025 presentation on diagnosing pelvic venous disorders with duplex sonography.
Dr Tobias Hirsch discusses his LINC 2025 presentation on diagnosing pelvic venous disorders with duplex sonography.
Dr Tobias Hirsch discusses his...
01/28/2025
Vascular Disease Management
Dr Schlager
LINC 2024
Quality of Life PROMinance Vital in Venous Interventions
05/29/2024

Oliver Schlager, MD
Medical University of Vienna, Austria

Oliver Schlager, MD Medical Universit...
Quality of life assessments were explored in detail on Tuesday morning by Oliver Schlager, who talked about the severity of venous insufficiency and post-thrombotic syndrome, which are typically assessed by the Villalta scale.
Quality of life assessments were explored in detail on Tuesday morning by Oliver Schlager, who talked about the severity of venous insufficiency and post-thrombotic syndrome, which are typically assessed by the Villalta scale.
Quality of life assessments were...
05/29/2024
Vascular Disease Management
Dr Suai
LINC 2024
AVF Treatment Leaves a Great IMPRESSION
05/28/2024

Tan Chieh Suai
Singapore General Hospital, Singapore

Tan Chieh Suai Singapore General Hosp...
The first data from a randomized controlled trial looking into the treatment of arteriovenous fistula (AVF) stenosis was announced today by Dr Tan Chieh Suai from Singapore General Hospital.
The first data from a randomized controlled trial looking into the treatment of arteriovenous fistula (AVF) stenosis was announced today by Dr Tan Chieh Suai from Singapore General Hospital.
The first data from a randomized...
05/28/2024
Vascular Disease Management
Dr Montero-Baker
LINC 2023
PROMISE-ing Updates for Percutaneous Deep Vein Arterialization
06/08/2023
Transcatheter arterialization of the deep veins is safe and effective, and offers a potential new treatment option for patients facing amputation.
Transcatheter arterialization of the deep veins is safe and effective, and offers a potential new treatment option for patients facing amputation.
Transcatheter arterialization of...
06/08/2023
Vascular Disease Management
Dr Ferraresi
LINC 2023
Deep Venous Arterialization: How Does It Work?
06/07/2023
Roberto Ferraresi, MD
Although revascularization options have substantially improved in recent years, ~20% of CLTI patients are still considered not suitable for any type of traditional revascularization.
Although revascularization options have substantially improved in recent years, ~20% of CLTI patients are still considered not suitable for any type of traditional revascularization.
Although revascularization...
06/07/2023
Vascular Disease Management
Dr Desai
LINC 2023
Thrombectomy for DVT: Tips on Patient Selection and Procedure
06/07/2023
Kush Desai, MD
The questions of when and how to employ thrombectomy for DVT were addressed by Dr Kush Desai during a VIVA@LINC session on Wednesday.
The questions of when and how to employ thrombectomy for DVT were addressed by Dr Kush Desai during a VIVA@LINC session on Wednesday.
The questions of when and how to...
06/07/2023
Vascular Disease Management
Dr Almoaiqel
LINC 2023
Varicose Veins: Updates in Thermal and Non-thermal Ablation
06/06/2023
Mohammed Almoaiqel, MD, FRCPC
Dr Almoaiqel provides insight into his Tuesday afternoon session at LINC 2023.
Dr Almoaiqel provides insight into his Tuesday afternoon session at LINC 2023.
Dr Almoaiqel provides insight...
06/06/2023
Vascular Disease Management
Dr Gary Ansel
LINC 2023
FlowTriever Embolectomy for Acute Pulmonary Embolism
06/06/2023
Dr Gary Ansel discusses the FlowTriever System (Inari Medical), the first mechanical thrombectomy device indicated for the treatment of pulmonary embolism.
Dr Gary Ansel discusses the FlowTriever System (Inari Medical), the first mechanical thrombectomy device indicated for the treatment of pulmonary embolism.
Dr Gary Ansel discusses the...
06/06/2023
Vascular Disease Management
Dr Brodmann
ISET 2025
Current State of Paclitaxel Drug-Coated Balloons and Drug-Eluting Stents
02/04/2025
Marianne Brodmann, MD
Marianne Brodmann, MD, presented an in-depth review of drug-coated balloons and drug-eluting stents for treating peripheral arterial disease.
Marianne Brodmann, MD, presented an in-depth review of drug-coated balloons and drug-eluting stents for treating peripheral arterial disease.
Marianne Brodmann, MD, presented...
02/04/2025
Vascular Disease Management
Dr Sag
ISET 2025
Thyroid Artery Embolization vs Ablation
02/03/2025
Alan A. Sag, MD
Alan Alper Sag, MD, presented a discussion at ISET 2025 that compared thyroid artery embolization and radiofrequency ablation as minimally invasive alternatives to traditional surgical and medical treatments for thyroid disorders.
Alan Alper Sag, MD, presented a discussion at ISET 2025 that compared thyroid artery embolization and radiofrequency ablation as minimally invasive alternatives to traditional surgical and medical treatments for thyroid disorders.
Alan Alper Sag, MD, presented a...
02/03/2025
Vascular Disease Management
Dr Korngold
ISET 2025
An Industry Perspective on the Carotid Space
02/03/2025
Ethan C. Korngold, MD
Ethan Korngold, MD, chief medical officer at Abbott Vascular, provides an industry perspective on the evolving role of carotid artery stenting in stroke prevention.
Ethan Korngold, MD, chief medical officer at Abbott Vascular, provides an industry perspective on the evolving role of carotid artery stenting in stroke prevention.
Ethan Korngold, MD, chief...
02/03/2025
Vascular Disease Management
Dr Yeung
ISET 2025
The Treatment of PAD and the Role of AI
02/03/2025
Kak Khee Yeung, MD, from Amsterdam UMC in the Netherlands, gave a presentation at ISET 2025 that explored the integration of artificial intelligence into the treatment of peripheral arterial disease.
Kak Khee Yeung, MD, from Amsterdam UMC in the Netherlands, gave a presentation at ISET 2025 that explored the integration of artificial intelligence into the treatment of peripheral arterial disease.
Kak Khee Yeung, MD, from...
02/03/2025
Vascular Disease Management
Dr AbuRahma
ISET 2025
Natural History/Late Neuro Events of Asymptomatic vs. Symptomatic Subclavian Steal as Detected by Duplex Ultrasound
02/02/2025
Vascular surgeon Ali F. AbuRahma, MD, presented on the topic of late neuro events of asymptomatic vs subclavian steal syndrome.
Vascular surgeon Ali F. AbuRahma, MD, presented on the topic of late neuro events of asymptomatic vs subclavian steal syndrome.
Vascular surgeon Ali F....
02/02/2025
Vascular Disease Management
Dr Pellerito
ISET 2025
Renal and Mesenteric Pathologies
02/02/2025
At ISET 2024, John S. Pellerito, MD, vice chair of radiology at the Zucker School of Medicine, Northwell Health, delivered an in-depth presentation on renal and mesenteric vascular pathologies.
At ISET 2024, John S. Pellerito, MD, vice chair of radiology at the Zucker School of Medicine, Northwell Health, delivered an in-depth presentation on renal and mesenteric vascular pathologies.
At ISET 2024, John S. Pellerito,...
02/02/2025
Vascular Disease Management
Dr Bauer
ISET 2025
The Role of Vascular Nurses and Advanced Practice Providers in Patient Selection and Perioperative Care
02/02/2025
Karen Bauer, DNP, APRN-FNP, CWS, DAPWCA, NP-C
Karen Bauer, DNP, CWS, FAAWC, presented a session on the critical role that vascular nurses and advanced practice providers (APPs) play in patient selection, perioperative care, and overall vascular disease management.
Karen Bauer, DNP, CWS, FAAWC, presented a session on the critical role that vascular nurses and advanced practice providers (APPs) play in patient selection, perioperative care, and overall vascular disease management.
Karen Bauer, DNP, CWS, FAAWC,...
02/02/2025
Vascular Disease Management
Dr Harnain
ISET 2025
Case Studies & Discussion: Venous Compression Syndromes
02/02/2025
Read about Dr Christopher M. Harnain's ISET 2025 presentation on venous compression syndromes.
Read about Dr Christopher M. Harnain's ISET 2025 presentation on venous compression syndromes.
Read about Dr Christopher M....
02/02/2025
Vascular Disease Management
Dr Babaev
ISET 2025
Thirty-Day Outcomes From the Disrupt PAD BTK II Study
01/31/2025
Anvar Babaev, MD, PhD
At ISET 2025, Anvar Babaev, MD, PhD, presented findings from the Disrupt PAD BTK II study, a prospective, multicenter trial assessing the efficacy and safety of Shockwave IVL in treating calcified below-the-knee PAD.
At ISET 2025, Anvar Babaev, MD, PhD, presented findings from the Disrupt PAD BTK II study, a prospective, multicenter trial assessing the efficacy and safety of Shockwave IVL in treating calcified below-the-knee PAD.
At ISET 2025, Anvar Babaev, MD,...
01/31/2025
Vascular Disease Management
Dr Kandzari
ISET 2025
Will Renal Denervation Have an Important Role in the Treatment of Hypertension?
01/31/2025
David E. Kandzari, MD
David E. Kandzari, MD, FACC, MSCAI gave a presentation at ISET 2025 where he examined renal denervation as a potential new standard in hypertension treatment.
David E. Kandzari, MD, FACC, MSCAI gave a presentation at ISET 2025 where he examined renal denervation as a potential new standard in hypertension treatment.
David E. Kandzari, MD, FACC,...
01/31/2025
Vascular Disease Management

Stay in the Know

Vascular Disease Management Newsletter

News

Late-Breaking Trials
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/05/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/05/2024
Vascular Disease Management
Late-Breaking Trials
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Pulmonary Embolism
Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism
11/04/2024
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate...
11/04/2024
Vascular Disease Management
Zilver Vena Stent
Zilver Vena Stent Shows High Patency Across All Patient Groups in Three-Year Clinical Study
10/29/2024
Bloomington, Ind. — Cook Medical’s Zilver Vena® Venous Self-Expanding Stent has shown high rates of patency sustained for three years, according to recently published data in the Journal of Vascular and Interventional Radiology (JVIR).1 The...
Bloomington, Ind. — Cook Medical’s Zilver Vena® Venous Self-Expanding Stent has shown high rates of patency sustained for three years, according to recently published data in the Journal of Vascular and Interventional Radiology (JVIR).1 The...
Bloomington, Ind. — Cook...
10/29/2024
Vascular Disease Management
Venous Disease
New Randomized Controlled Data From Venaseal Spectrum Program Reinforces Evidence That Venaseal™ Closure System Is Safe and Effective
04/24/2024

Medtronic News Alert

Medtronic News Alert
Medtronic, the global leader in healthcare technology, today announced the VenaSeal Spectrum Program primary endpoints and 30-day modified Aberdeen Varicose Vein Questionnaire (AVVQ) results on the use of the VenaSeal™ closure system compared...
Medtronic, the global leader in healthcare technology, today announced the VenaSeal Spectrum Program primary endpoints and 30-day modified Aberdeen Varicose Vein Questionnaire (AVVQ) results on the use of the VenaSeal™ closure system compared...
Medtronic, the global leader in...
04/24/2024
Vascular Disease Management
News
Clarius and ThinkSono Introduce a New AI-Guided Ultrasound System Enabling Rapid Assessments of DVTs
04/05/2024

Clarius Mobile Health News

Clarius Mobile Health News
Having achieved CE Mark for sales in Europe and the UK, ThinkSono is now collaborating with Clarius on clinical studies in the United States to prepare for FDA submission VANCOUVER, BC, April 5, 2024 /PRNewswire/ -- Clarius Mobile Health,...
Having achieved CE Mark for sales in Europe and the UK, ThinkSono is now collaborating with Clarius on clinical studies in the United States to prepare for FDA submission VANCOUVER, BC, April 5, 2024 /PRNewswire/ -- Clarius Mobile Health,...
Having achieved CE Mark for...
04/05/2024
Vascular Disease Management
News
AngioDynamics Receives 510(k) Clearance for AlphaVac F1885 System in Treatment of PE
04/04/2024

AngioDynamics News

AngioDynamics News
New Indication for Treatment of Pulmonary Embolism Enhances Device Utility in Critical Medical Scenarios April 04, 2024  LATHAM, N.Y.--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company...
New Indication for Treatment of Pulmonary Embolism Enhances Device Utility in Critical Medical Scenarios April 04, 2024  LATHAM, N.Y.--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company...
New Indication for Treatment of...
04/04/2024
Vascular Disease Management
News
Baylis Medical Technologies Announces Launch of PowerWire® Pro RF Guidewire, Enhancing Access to Care for Patients with Occluded Venous Stents
03/20/2024

Baylis Medical Technologies

Baylis Medical Technologies
MISSISSAUGA, ON, March 18, 2024 – Baylis Medical Technologies Inc. announced the 510(k) clearance and launch of the PowerWire® Pro Radiofrequency (RF) Guidewire in the United States, facilitating venous stent recanalization for total...
MISSISSAUGA, ON, March 18, 2024 – Baylis Medical Technologies Inc. announced the 510(k) clearance and launch of the PowerWire® Pro Radiofrequency (RF) Guidewire in the United States, facilitating venous stent recanalization for total...
MISSISSAUGA, ON, March 18, 2024...
03/20/2024
Vascular Disease Management
News
Jennifer Fried Joins Flow Medical as CEO and Co-Founder
08/31/2023

Flow Medical press release

Flow Medical press release
August 31, 2023 - Flow Medical, a physician-founded developer of a novel thrombolytic catheter to treat pulmonary embolism, today announced that Jennifer Fried has been named as Chief Executive Officer and Co-Founder.   Fried has spent...
August 31, 2023 - Flow Medical, a physician-founded developer of a novel thrombolytic catheter to treat pulmonary embolism, today announced that Jennifer Fried has been named as Chief Executive Officer and Co-Founder.   Fried has spent...
August 31, 2023 - Flow Medical,...
08/31/2023
Vascular Disease Management
News
Cook Medical Treats First Patient in First-in-human Clinical Trial for Venous Valve
05/01/2023
Bloomington, Ind. — Cook Medical announces the first patient treated in a clinical study to evaluate a new venous valve designed for treating chronic venous insufficiency. The patient was treated by Dr. Mauricio Alviar, vascular surgeon and...
Bloomington, Ind. — Cook Medical announces the first patient treated in a clinical study to evaluate a new venous valve designed for treating chronic venous insufficiency. The patient was treated by Dr. Mauricio Alviar, vascular surgeon and...
Bloomington, Ind. — Cook Medical...
05/01/2023
Vascular Disease Management
VentiV Clinical Images
Thrombectomy
FDA Clears New Mechanical Thrombectomy System
03/31/2025
VentiV Scientific announced the FDA clearance of VentiV Mechanical Thrombectomy system to remove blood clots from the peripheral vasculature including the new VentiV Pulse platform.
VentiV Scientific announced the FDA clearance of VentiV Mechanical Thrombectomy system to remove blood clots from the peripheral vasculature including the new VentiV Pulse platform.
VentiV Scientific announced the...
03/31/2025
Cath Lab Digest
Restenosis
Real-world Data Shows Cook’s Zilver PTX Leads to Lower Rates of In-stent Occlusion Than Boston Scientific’s Eluvia
03/27/2025
Bloomington, Ind. — Cook Medical’s Zilver PTX drug-eluting stent (DES) has lower rates of in-stent occlusions among patients with restenosis at 3 years than Boston Scientific’s Eluvia DES, according to real-world data from the REALDES study....
Bloomington, Ind. — Cook Medical’s Zilver PTX drug-eluting stent (DES) has lower rates of in-stent occlusions among patients with restenosis at 3 years than Boston Scientific’s Eluvia DES, according to real-world data from the REALDES study....
Bloomington, Ind. — Cook...
03/27/2025
Vascular Disease Management
TAVR
Medtronic’s Evolut Trial Outcome Could Shake Up US TAVR Market, Says GlobalData
03/21/2025
Medtronic has released results from the two-year point of a clinical trial comparing its Evolut to Edwards Lifesciences’ SAPIEN. The results revealed that the Evolut showed superior performance to the SAPIEN. Specifically, the Evolut showed...
Medtronic has released results from the two-year point of a clinical trial comparing its Evolut to Edwards Lifesciences’ SAPIEN. The results revealed that the Evolut showed superior performance to the SAPIEN. Specifically, the Evolut showed...
Medtronic has released results...
03/21/2025
Vascular Disease Management
Embolotherapy
Instylla Completes Submission of Premarket Approval Application for Embrace™ Hydrogel Embolic System
03/11/2025
BEDFORD, Mass., March 11, 2025 /PRNewswire/ -- Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolotherapy, announced that it recently submitted to the U.S. Food and Drug Administration...
BEDFORD, Mass., March 11, 2025 /PRNewswire/ -- Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolotherapy, announced that it recently submitted to the U.S. Food and Drug Administration...
BEDFORD, Mass., March 11, 2025...
03/11/2025
Vascular Disease Management
Resistant Hypertension
Corcept Therapeutics Initiates MOMENTUM Trial to Determine Prevalence of Hypercortisolism in Patients with Resistant Hypertension
03/10/2025
“Resistant hypertension is a serious public health challenge. Patients whose hypertension remains in poor control despite receiving optimal care, including multiple medications, are at greater risk of cardiovascular morbidity and mortality,”...
“Resistant hypertension is a serious public health challenge. Patients whose hypertension remains in poor control despite receiving optimal care, including multiple medications, are at greater risk of cardiovascular morbidity and mortality,”...
“Resistant hypertension is a...
03/10/2025
Cath Lab Digest
Company expansion
Reflow Medical Expands Global Reach With New European Subsidiary
03/06/2025
Reflow Medical, Inc., a developer of innovative medical devices for complex cardiovascular disease, has announced the opening of its European subsidiary in Landsberg am Lech, Germany.
Reflow Medical, Inc., a developer of innovative medical devices for complex cardiovascular disease, has announced the opening of its European subsidiary in Landsberg am Lech, Germany.
Reflow Medical, Inc., a...
03/06/2025
Cath Lab Digest
SCAI
Survey Confirms Radiation and Orthopedic Health Hazards in Cardiac Catheterization Laboratories are ‘Unacceptable’
03/05/2025
A survey conducted by the Society for Cardiovascular Angiography and Interventions (SCAI) highlights ongoing radiation and orthopedic hazards faced by interventional cardiologists and cardiac catheterization laboratory (“cath lab” or CCL)...
A survey conducted by the Society for Cardiovascular Angiography and Interventions (SCAI) highlights ongoing radiation and orthopedic hazards faced by interventional cardiologists and cardiac catheterization laboratory (“cath lab” or CCL)...
A survey conducted by the...
03/05/2025
Cath Lab Digest
Shockwave Javelin Peripheral IVL Catheter, a novel intravascular lithotripsy (IVL) platform designed to modify calcium and cross extremely narrowed vessels in patients with peripheral artery disease (PAD).
IVL
Shockwave Medical Launches Novel Forward Intravascular Lithotripsy Platform in U.S. to Transform Treatment of Difficult-to-Cross Calcified Lesions
03/04/2025
Now available in the U.S., the Shockwave Javelin Peripheral Intravascular Lithotripsy Catheter safely modifies and crosses occlusive or extremely narrowed calcific peripheral artery disease.
Now available in the U.S., the Shockwave Javelin Peripheral Intravascular Lithotripsy Catheter safely modifies and crosses occlusive or extremely narrowed calcific peripheral artery disease.
Now available in the U.S., the...
03/04/2025
Cath Lab Digest
Acute Ischemic Stroke
FDA Approves Genentech’s TNKase® in Acute Ischemic Stroke in Adults
03/03/2025
Genentech announced that the U.S. FDA has approved TNKase® (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.
Genentech announced that the U.S. FDA has approved TNKase® (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.
Genentech announced that the...
03/03/2025
Vascular Disease Management
TEVAR
Zenith Alpha Thoracic 2 Now Available in US; First Case Performed
03/03/2025
Cook Medical’s Zenith Alpha® 2 Thoracic Endovascular Graft (ZTA2) is now commercially available throughout the United States.
Cook Medical’s Zenith Alpha® 2 Thoracic Endovascular Graft (ZTA2) is now commercially available throughout the United States.
Cook Medical’s Zenith Alpha® 2...
03/03/2025
Vascular Disease Management

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use